December 8, 2011 – Cinilabs today announced that that Mr. James Meringolo has joined the company as Vice President of Finance.
October 31, 2011 – Cinilabs today announced that its President and CEO, Dr. Gary Zammit, will present at the New England Regional Chapter Society of Quality Assurance (NERCSQA) Good Clinical Practices (GCP) training in Framingham, MA.
September 29, 2011 – Cinilabs today announced that it has received approval to begin a clinical study to evaluate the safety and effectiveness of the Apnex® Hypoglossal Nerve Stimulation (HGNS®) System to treat obstructive sleep apnea (OSA), becoming one of the first medical centers in the country to participate in this study.
August 24, 2011 – Clinilabs today announced that it has been selected to conduct a Phase I clinical trial of an investigational new drug for insomnia.
July 11, 2011 – Clinilabs today announced that it has been selected to conduct a clinical research study of the effects of an investigational medication on the sleep of healthy volunteers.
June 21, 2011 – Clinilabs has entered into a strategic alliance with Ambulatory Monitoring, Inc. (AMI), a medical device and service company.
June 15, 2011 – Clinilabs today announced that the company will exhibit at the Drug Information Association 47th Annual Meeting in Chicago, IL.
June 8, 2011 – Clinilabs today announced that they have been selected to conduct a Phase 2 clinical research study of an investigational medication in patients with Major Depressive Disorder.
May 24, 2011 – Clinilabs today announced that they have been selected to conduct a Phase 1 clinical research study of an investigational patch medication.
May 9, 2011 – Clinilabs today announced that President and CEO, Dr. Gary Zammit, will participate as a speaker and discussant in an FDA-PERI co-sponsored workshop on the safety and efficacy of hypnotic drugs.
April 15, 2011 – Clinilabs today announced that they have been selected to conduct a Phase I clinical research study of an investigational medication in patients with Obstructive Sleep Apnea (OSA).
April 6, 2011 – Clinilabs today announced that they have been selected to conduct a Phase I clinical research study of an investigational medication in patients with Chronic Obstructive Pulmonary Disease (COPD).
March 23, 2011 – Clinilabs today announced that Dr. Richard Johnson has joined its Advisory Board.
February 8, 2011 – Clinilabs today announced the arrival of Stephen Murray, MD, PhD, to the position of Chief Medical Officer (CMO).
|
